ijms-logo

Journal Browser

Journal Browser

Evolving Landscape of Cardiovascular Pathophysiology

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: 25 July 2026 | Viewed by 74

Special Issue Editor


E-Mail Website
Guest Editor
Center for Metabolic and Degenerative Diseases, The Brown Foundation Institute of Molecular Medicine for Prevention of Human Diseases, UTHealth-McGovern Medical School, Houston, TX 77030, USA
Interests: complement immunity; complement anaphylatoxin receptor signaling; complement role in autoimmune and infectious diseases; complement dysfunction in rheumatoid arthritis-related cardiopulmonary fibrosis

Special Issue Information

Dear Colleagues,

Cardiovascular diseases (CVDs) continue to represent the leading cause of morbidity and mortality globally, causing a significant healthcare burden, despite the fact that prevention and treatment methods have advanced considerably. Understanding the underlying pathophysiological mechanisms is essential in developing innovative therapies and improving patient outcomes. Drawing on current trends and recent breakthroughs in the field of cardiovascular medicine, this Special Issue, “Evolving Landscape of Cardiovascular Pathophysiology”, will bring together cutting-edge research articles and comprehensive reviews that illuminate the complex biological processes driving cardiovascular disorders. We will focus on transformative developments that are reshaping our understanding and treatment of heart disease. Contributions should highlight the convergence of cutting-edge technologies and traditional research to bridge the gap between bench science and clinical applications. This Special Issue will feature research exploring emerging cardio-metabolic insights, including endothelial metabolomics, inflammatory mechanisms, and single-cell transcriptomics in cardiac adversities in humans and experimental models. Insights into the gut–heart axis, including the role of gut dysbiosis in promoting atherosclerosis, hypertension, and heart failure, can aid in identifying potential therapeutic targets for balancing the gut microbiota. We also welcome research on AI-based technologies for predicting conditions such as cardiomyopathies and heart failure. We also encourage work on precision diagnostics and therapeutic innovations for this Special Issue.

Dr. Pooja Shivshankar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomarker discovery in cardiovascular pathophysiology
  • precision diagnostics-novel contrast agents combined with PET/CT, MRI
  • machine learning/AI and clinical implementations in cardiology
  • cardio-metabolic disease, inflammation and immunity in cardiovascular diseases, mechanisms of non-coding RNAs and microRNAs in cardiac diseases
  • translational research in large animals bridging the rodent re-search with human pathophysiology
  • targeted therapies- genetic therapies/gene editing approach (CRISPR), stem cell therapies, and therapeutic mRNA and siRNA-based approaches

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop